Replies to post #19872 on NDT Pharmaceuticals Inc (NDTP)

[Bivins]

Agreed. If Passalaqua was able to issue himself 42 million shares at .000123, that leads me to believe the insiders couldn’t care less about this failed endeavor.

Therefore, “The Company is now focused on developing products to utilizing the intellectual property described above.” taken from OTCMarkets, which was verified today, is complete BS.

Let’s see some transparency Passalaqua